Airlock Alpha
From Wikipedia, the free encyclopedia
Airlock Alpha, formerly SyFy Portal, was an entertainment news website focusing on science-fiction, fantasy and comic book television series and films.
 | The topic of this article may not meet Wikipedia's notability guideline for web content. (February 2022) |
 | |
Type of site | Science-fiction/fantasy entertainment news |
|---|---|
| Headquarters | Tampa, Florida , USA |
| Owner | Nexus Media Group Inc.[1] |
| Created by | Michael Hinman Greg Boubel |
| URL | www |
| Commercial | Yes |
| Registration | None |
| Launched | August 13, 1998 |
History
After a collaboration between Michael Hinman and Greg Boubel,[1] the site debuted August 13, 1998, as "Syfyman's World", later renamed "SyFy World". In 2000, SyFy World became part of Trek Nation, the parent network of TrekToday. In 2001, the site merged with the Star Trek Portal website and relaunched as "SyFy Portal".
The website announced a rebranding under the new name of Airlock Alpha on February 23, 2009. No reason outside of a new marketing strategy was given for the name change at the time, but on March 16, 2009, Sci Fi Channel announced that it was changing its name to Syfy,[2] and Airlock Alpha revealed that it had sold its former brand name to an undisclosed party a month earlier.[3]
Portal Awards
Airlock Alpha created the Genre Awards in 1999, which has handed out awards for genre television and movies nearly every year since.[4] It is based upon fan-based voting.[5] The awards were later renamed as the Portal Awards.[4]
Categories
- Best Actor – Television[6]
- Best Actress – Television[6]
- Best Supporting Actor – Television[6]
- Best Supporting Actress – Television[6]
- Best Episode – Television[6]
- Best Guest Star – Television[6]
- Best Young Actor[6]
- Best Actor – Movie[6]
- Best Actress – Movie[6]
- Best Web Site[6]
- Best Web Production[6]
- Best Movie[6]
- Best Series – Television[6]
- Gene Roddenberry Lifetime Achievement Award[6]
See also
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.